Search results for " drug delivery"

Article Bioterminology: A Guide to the Biopharmaceutical Lexicon
(See pre-license inspection)  parenteral delivery Drug delivery by injection; subcutaneous, intra-muscular, and intravenous delivery are most common. Drug must be sterile.  particle filtratio…

Article A Look Ahead at BioPharma Manufacturing and Regulation
The FDA talks about the changing scope of regulatory science. Regulatory science underpins innovation and practices in drug manufacturing. The most common definition of r…

Article A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU Legal experts in biopharmaceutical patent law shed some light on trends and recent news. By Agnes Shanley …

Article Advances in Linker Technology: Improving the Safety and Efficacy of Antibody Drug Conjugates
The targeted delivery of cytotoxic drugs using antibody drug conjugates would not be possible without effective linkers to connect and then release the key chemical and biological materials. …

Article Biopharma Seeks Balance
Biopharma Seeks Balance Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science. By Rita C. Peters …

Article Quality by design for biotechnology products—part 2
Second in a three-part series that discusses the complexities of QbD implementation in biotech development. By Taruna Arora, Roger Greene, Jennifer Mercer, Paul Tsang, Meg Casais, Stuart Feldman…

Article Framing Biopharma Success in 2016
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016. By Rita C. Peters The US biopharmaceutical industry turned a new page in 2015 when…

Article mAbs to Watch in 2016
By Randi Hernandez Of the 45 new molecular entities and new therapeutic biological products approved by FDA in 2015, nine products were monoclonal antibodies (mAbs). And there may be many more o…

Article Biopharma Advances Demand Specialized Expertise
Jun 15, 2015 By BioPharm International Editors BioPharm International eBooks Volume 28, Issue 13 Contract service providers share insights on biopharma market developments and the impl…

Article Transformative Medicines Challenge FDA and Manufacturers
FDA officials emphasize the importance of achieving consistency throughout the agency in making timely decisions on combination product oversight to support the development and approval of innovative …

Next Page